Drug Trial Radar · NCT07138274
Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Oct 19, 2026
Primary completion
Jun 2031
Study completion Dec 2031
Sponsor
- Lead sponsor
- Mayo ClinicAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
single-center, randomized, double-blind, placebo-controlled Phase 2 study to evaluate safety and efficacy of overnight metyrapone in patients with MACS.
Conditions
- Mild Autonomous Cortisol Secretion (MACS)
- Autonomous Cortisol Secretion (ACS)
Interventions
Metyrapone 250 mg Oral TabletsDrug
Subjects will receive metyrapone beginning at 500 mg and titrating up to 1000 mg
PlaceboDrug
Subjects will receive placebo at 500 mg dose and titrated up to 1000 mg to match interventional arm and prevent unblinding
Primary outcomes
What the sponsor says the trial is designed to measure.
- Glucocorticoid to androgen ratioTime frame: 3 and 6 months
- Delta salivary cortisoneTime frame: 3 and 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mayo Clinic
Rochester, Minnesota · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.